Trial intelligence / Profile preview

Sitagliptin versus placebo for beta-cell function after acute coronary syndrome with newly detected glucose abnormalities

2007-003963-31Phase 3Completed

Sponsor
Karolinska Institutet
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in prediabetes and type 2 diabetes mellitus (T2DM) comparing Sitagliptin arm with Placebo arm (2 arms). Started Aug 2007; status: completed.

02

Drugs

sitagliptin
03

Conditions

prediabetestype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2007-003963-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003963-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call